11:55 AM EST - Cognetivity Neurosciences Ltd : Today announces that it has signed an agreement to conduct a broad-scale paid pilot project with a large national US provider of healthcare services. The Paid Project will run for a period of 12 months. It will see CognICATM, the Company's proprietary brain health screening technology, be deployed across a minimum of three but potentially dozens of the Client's facilities. CognICATM will be used to assess the brain health of the Client's patients who present with unexplained behavioural disturbances. Cognetivity Neurosciences Ltd
shares C.CGN are trading unchanged at $0.28.
